Al-Ola A Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of HMCT at the University of Kansas Medical Center, shared a post on X:
“Now on stage: Dr. Mewawalla presenting Advances in CAR-T Therapies in Myeloma — pushing the boundaries of innovation in patient care!”
Prerna Mewawalla, Myeloma and Transplant Physician, Associate Professor at Drexel University, shared a post by IPO, adding։
“Great to contribute at ICET Congress with a presentation on Advances in CAR-T Therapies for Myeloma. Continued innovation in this field is shaping earlier integration, enhancing durability, and improving patient outcomes. Looking forward to next-generation constructs including anito-cel, arlo-cel, NK-CARs, and dual-targeted approaches.”
More from Al-Ola A Abdallah on OncoDaily.